Last $4.21 USD
Change Today +0.06 / 1.45%
Volume 15.4K
As of 5:20 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

skystar bio-pharmaceutical (SKBI) Key Developments

Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal 2014

Skystar Bio Pharmaceutical Company announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $18,352,693 against $15,992,408 a year ago. Income from operations was $5,399,574 against $4,737,701 a year ago. Net income was $4,909,453 against $3,734,197 a year ago. Income before provision for income taxes was $5,622,387 against $4,516,174 a year ago. Diluted earnings per share were $0.57 against basic and diluted earnings per share of $0.49 a year ago. For the nine months, the company reported revenue of $39,424,886 against $32,858,294 a year ago. Income from operations was $9,939,652 against $10,354,234 a year ago. Net income was $8,695,663 against $8,197,811 a year ago. Income before provision for income taxes was $10,521,013 against $9,997,829 a year ago. Diluted earnings per share were $1.08 against basic and diluted earnings per share of $1.08 a year ago. Net cash provided operating activities was $15,244,465 against net cash used in operating activities of $9,092,042 a year ago. Purchases of property, plant and equipment were $8,645 against $9,290 a year ago. The company reiterated its fiscal 2014 guidance to be in the range of $46 million to $50 million for the full year.

Skystar Bio Pharmaceutical Company to Report Q3, 2014 Results on Nov 14, 2014

Skystar Bio Pharmaceutical Company announced that they will report Q3, 2014 results at 5:00 PM, China Standard Time on Nov 14, 2014

Skystar Bio Pharmaceutical Company, Q3 2014 Earnings Call, Nov 14, 2014

Skystar Bio Pharmaceutical Company, Q3 2014 Earnings Call, Nov 14, 2014

Skystar Bio Pharmaceutical Company, Annual General Meeting, Dec 04, 2014

Skystar Bio Pharmaceutical Company, Annual General Meeting, Dec 04, 2014., at 19:45 China Standard Time. Location: 4/F Building B Chuangye Square. Agenda: To elect directors, each to serve until the next annual meeting of shareholders or until each successor is duly elected and qualified; to ratify the appointment of Crowe Horwath (HK) CPA Limited as the company's independent registered public accounting firm for the year ending December 31, 2014; and to transact any other business that is properly brought before the annual meeting or any adjournment or postponement thereof.

Skystar Bio Mulls Acquisitions

Skystar Bio Pharmaceutical Company (NasdaqCM:SKBI) is seeking acquisitions. Bing Mei, Chief Financial Officer of Skystar, Bio said, "we are in contract with a third party to look for the kind of strategic acquisition opportunity to acquire the technology to acquire the other business". Scott Cramer, Director Corporate Development & US Representative, Skystar Bio, said, "To be clear, we have not identified acquisition targets but we have placed on deposit with the third-party company for lack of a better term, earnest money, so they know we are serious. Since we have not identified a target we cannot say how long we will be looking."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKBI:US $4.21 USD +0.06

SKBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Animal Husbandry Industry Co Ltd CNY17.40 CNY -0.14
Guangdong VTR Bio-Tech Co Ltd CNY31.09 CNY +0.11
Inner Mongolia Jinyu Group Ltd CNY50.28 CNY +0.01
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd CNY14.22 CNY 0.00
View Industry Companies
 

Industry Analysis

SKBI

Industry Average

Valuation SKBI Industry Range
Price/Earnings 3.0x
Price/Sales 0.7x
Price/Book 0.3x
Price/Cash Flow 3.3x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.